Trigon HA Stand-Alone Wedge Fixation System

K193414 · Nvision Biomedical Technologies, Inc. · PLF · Feb 25, 2020 · Orthopedic

Device Facts

Record IDK193414
Device NameTrigon HA Stand-Alone Wedge Fixation System
ApplicantNvision Biomedical Technologies, Inc.
Product CodePLF · Orthopedic
Decision DateFeb 25, 2020
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 888.3030
Device ClassClass 2
AttributesTherapeutic

Intended Use

The Trigon™ HA Stand-Alone Wedge Fixation System is intended to be used for internal bone fixation for bone fractures or osteotomies in the foot, such as: - · Cotton (opening wedge) osteotomies of the medial cuneiform - · Evans lengthening osteotomies The Trigon Ti wedges are intended for use with ancillary fixation. The Trigon Ti Stand-Alone Wedge Fixation System is not intended for use in the spine.

Device Story

System consists of PEEK Optima HA Enhanced (HA PEEK) wedges with tantalum markers; used for angular correction of small foot bones. Wedges feature rectangular or kidney-shaped footprints (16x16mm to 20x22mm), thicknesses (5-12mm), surface teeth, and graft containment areas. Includes 2.5mm diameter titanium screws (10-30mm lengths). Used by surgeons in clinical settings for internal bone fixation. Wedges function as stand-alone fixation with provided screws or with ancillary plating/fixation. Device provides structural support and angular correction during bone healing; benefits patient by stabilizing osteotomy sites.

Clinical Evidence

Bench testing only. Testing included compression (ASTM F2077), expulsion, and engineering analysis of screw mechanical strength and pullout strength. No clinical data provided.

Technological Characteristics

Materials: PEEK Optima HA Enhanced (HA PEEK) and titanium screws. Features: Tantalum markers, surface teeth, graft containment area. Dimensions: 16x16mm to 20x22mm footprints; 5-12mm thicknesses; 2.5mm diameter screws. Mechanical testing per ASTM F2077.

Indications for Use

Indicated for internal bone fixation for foot fractures or osteotomies, specifically Cotton (medial cuneiform opening wedge) and Evans lengthening osteotomies. Not for use in the spine.

Regulatory Classification

Identification

Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.

Predicate Devices

Reference Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ February 25, 2020 Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. Nvision Biomedical Technologies, Inc. % Jeffrey Brittan Vice President of Product Realization Watershed Idea Foundry 1815 Aston Ave., Suite 106 Carlsbad, California 92008 Re: K193414 Trade/Device Name: Trigon HA Stand-Alone Wedge Fixation System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/Multiple Component Metallic Bone Fixation Appliances And Accessories Regulatory Class: Class II Product Code: PLF, HWC Dated: December 6, 2019 Received: December 9, 2019 Dear Jeffrey Brittan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal {1}------------------------------------------------ statutes and regulations administered by other Federal agencies. You must comply with all the Act's Page 2 requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely. Shumaya Ali. MPH Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ # Indications for Use 510(k) Number (if known) K193414 Device Name Trigon HA Stand-Alone Wedge Fixation System #### Indications for Use (Describe) The Trigon™ HA Stand-Alone Wedge Fixation System is intended to be used for internal bone fixation for bone fractures or osteotomies in the foot, such as: - · Cotton (opening wedge) osteotomies of the medial cuneiform - · Evans lengthening osteotomies The Trigon Ti wedges are intended for use with ancillary fixation. The Trigon Ti Stand-Alone Wedge Fixation System is not intended for use in the spine. | Type of Use (Select one or both, as applicable) | |-------------------------------------------------| |-------------------------------------------------| X | Prescription Use (Part 21 CFR 801 Subpart D) | | Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the logo for NVision biomedical technologies. The logo features a stylized "N" with horizontal lines on the left side, followed by the word "VISION" in a bold, sans-serif font. Below the main logo, the words "biomedical technologies" are written in a smaller, italicized font, with a gold color scheme. # 510(k) Summary DATE PREPARED February 6, 2020 # MANUFACTURER AND 510(k) OWNER Nvision Biomedical Technologies, Inc. 4590 Lockhill Selma San Antonio, TX 78249, USA Telephone: (210) 545-3713 Fax: (866) 764-1139 Official Contact: Diana Langham, Director of Regulatory and Corporate Compliance ## REPRESENTATIVE/CONSULTANT Jeffrey Brittan, Vice President of Product Realization Watershed Idea Foundry Telephone: (714) 287-6780 Email: jeffbrittan@watershedideas.com # PROPRIETARY NAME OF SUBJECT DEVICE Trigon™ HA Stand-Alone Wedge Fixation System COMMON NAME Bone Wedge ## DEVICE CLASSIFICATION Single/multiple component metallic bone fixation appliances and accessories (Classification Regulations: 21 CFR 888.3030, Product Codes: PLF, HWC. HRS, Class: II) PREMARKET REVIEW Orthopedic Device Panel Orthopedic Device Panel ## INDICATIONS FOR USE The Trigon HA Stand-Alone Wedge Fixation System is intended to be used for internal bone fixation for bone fractures or osteotomies in the foot, such as: - Cotton (opening wedge) osteotomies of the medial cuneiform ● - . Evans lengthening osteotomies The Trigon Ti wedges are intended for use with ancillary fixation. The Trigon Ti Stand-Alone Wedge Fixation System is not intended for use in the spine. {4}------------------------------------------------ Image /page/4/Picture/0 description: The image is a logo for Nvision biomedical technologies. The logo features a stylized "N" with horizontal lines emanating from it, followed by the word "VISION" in a modern, sans-serif font. Below the main text, in a smaller font, are the words "biomedical technologies". # DEVICE DESCRIPTION The Trigon HA Stand-Alone Wedge Fixation System is a family of PEEK Optima HA Enhanced (HA PEEK) wedges with tantalum markers used for angular correction of small bones of the foot. The wedges incorporate two screw-receiving holes, surface teeth, and an area to contain grafting material. The wedges are designed in rectangular and kidney shaped footprints in a range of sizes (16x16mm to 20x22mm) and in multiple thicknesses (5 to 12mm). The associated 2.5mm diameter titanium screws are designed in lengths of 10 to 30mm. When used with the provided screw fixation the Trigon wedges may be used with or without ancillary plating. When used without the provided screws Trigon wedges are intended for use with ancillary fixation. # PREDICATE DEVICE IDENTIFICATION The Trigon HA Stand-Alone Wedge Fixation System is substantially equivalent to the following predicates: | 510(k) Number | Predicate Device Name / Manufacturer | Primary<br>Predicate | |---------------|-----------------------------------------------------|----------------------| | K161037 | Life Spine Tarsa-Link Wedge Fixation System | | | K140531 | Wright Medical Technology BIOFOAM Bone Wedge | | | K151256 | Arthrex BioSync Wedge System | | | K192645 | Nvision Trigon Ti Stand-Alone Wedge Fixation System | | The following reference devices are also cited in this submission: - Nvision Biomedical's Vector Hammertoe Correction System (K183055) ● - . Nvision Biomedical's Healix Compression Screw System (K182949) - Siats LLC's T-Rex Standalone ALIF (K170855) ● # SUMMARY OF NON-CLINICAL TESTING No FDA performance standards have been established for the Trigon HA Stand-Alone Wedge Fixation System. The following testing was performed: - Compression (per ASTM F2077) - Expulsion - Engineering analysis to evaluate screw mechanical strength and pullout strength . The results of these tests indicate that the Trigon HA Stand-Alone Wedge Fixation System is substantially equivalent to the predicate devices. {5}------------------------------------------------ Image /page/5/Picture/0 description: The image shows the logo for NVision Biomedical Technologies. The logo features a stylized "N" with horizontal lines emanating from it, followed by the word "VISION" in a bold, sans-serif font. Below the main logo, the words "biomedical technologies" are written in a smaller, italicized font. # EQUIVALENCE TO PREDICATE DEVICES Nvision believes that the Trigon HA Stand-Alone Wedge Fixation System is substantially equivalent to the predicate devices. The subject wedges are similar to the predicates in that the footprint sizes and thicknesses are similar, they are intended for use with ancillary fixation, and they incorporate the same number of ancillary screws. Furthermore, the ancillary screws are similar in size. Trigon wedges are manufactured from HA PEEK while the primary predicate is manufactured from standard PEEK, however testing, analysis, and comparison to reference devices also manufactured from HA PEEK demonstrated that this does not negatively impact equivalence. #### CONCLUSION Based on the testing performed, including compression, expulsion, and engineering analysis, it can be concluded that the subject device does not raise new issues of safety or efficacy compared to the predicate devices. The similar indications for use, technological characteristics, and performance characteristics for the proposed Trigon HA Stand-Alone Wedge Fixation System are assessed to be substantially equivalent to the predicate devices.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%